CAS 1210344-83-4

Ertugliflozin L-Pyroglutamic Acid

Description:

Ertugliflozin L-Pyroglutamic Acid is a pharmaceutical compound primarily used in the management of type 2 diabetes mellitus. It functions as a sodium-glucose co-transporter 2 (SGLT2) inhibitor, which helps lower blood glucose levels by promoting the excretion of glucose through urine. The compound is characterized by its unique molecular structure, which includes both the ertugliflozin moiety and L-pyroglutamic acid, contributing to its pharmacological properties. It is typically administered orally and is known for its efficacy in improving glycemic control, as well as its potential benefits in weight management and cardiovascular health. The compound's safety profile is generally favorable, although it may be associated with certain side effects such as urinary tract infections and dehydration. As with any medication, it is essential for patients to consult healthcare professionals for personalized advice and monitoring while using this drug. Overall, Ertugliflozin L-Pyroglutamic Acid represents a significant advancement in diabetes treatment options.

Synonyms:

• Ertugliflozin L-pyroglutamic acid

Ertugliflozin L-pyroglutamic acid

CAS: 1210344-83-4

Formula: C₂₇H₃₂ClNO₁₀

Purity: 99%

Color and Shape: Solid

Molecular weight: 565.9967

Ref: IN-DA01V4DD

(S)-5-Oxopyrrolidine-2-Carboxylic Acid Compound With (1S,2S,3S,4R,5S)-5-(4-Chloro-3-(4-Ethoxybenzyl)Phenyl)-1-(Hydroxymethyl)-6,8-Dioxabicyclo[3.2.1]Octane-2,3,4-Triol (1:1)

CAS: 1210344-83-4

(S)-5-Oxopyrrolidine-2-Carboxylic Acid Compound With (1S,2S,3S,4R,5S)-5-(4-Chloro-3-(4-Ethoxybenzyl)Phenyl)-1-(Hydroxymethyl)-6,8-Dioxabicyclo[3.2.1]Octane-2,3,4-Triol (1:1)

Purity: 99%

Molecular weight: 566g/mol

Ref: 54-OR1025574

Ertugliflozin L-pyroglutamic acid

CAS: 1210344-83-4

Ertugliflozin L-pyroglutamic acid

Purity: ≥98%

Molecular weight: 566g/mol

Ref: 54-BUP15455

Ertugliflozin L-Pyroglutamic Acid

CAS: 1210344-83-4

Formula: C₂₂H₂₅ClO₇·C₅H₇NO₃

Color and Shape: White To Off-White Solid

Molecular weight: 436.88 129.12

Ref: 4Z-E-090003

Ertugliflozin-d5 L-Pyroglutamic Acid

CAS: 1210344-83-4

Formula: C₂₂H₂₀D₅ClO₇·C₅H₇NO₃

Molecular weight: 441.92 129.12

Ref: 4Z-E-090033

Ertugliflozin L-pyroglutamic Acid (1:1)

Controlled Product

CAS: 1210344-83-4

Formula: C₂₂H₂₅ClO₇·C₅H₇NO₃

Color and Shape: Neat

Molecular weight: 565.997

Ref: TR-E635095

Ertugliflozin L-Pyroglutamic Acid

CAS: 1210344-83-4

Formula: C₂₂H₂₅ClO₇C₅H₇NO₃

Molecular weight: 436.88 : 129.12

Ref: ST-EA-CP-E69017

Ertugliflozin L-pyroglutamic acid

CAS: 1210344-83-4

Ertugliflozin is a potent oral hSGLT2 inhibitor (IC50: 0.877 nM) for type 2 diabetes treatment studies.

Formula: C₂₇H₃₂ClNO₁₀

Purity: 99.88% - 99.94%

Color and Shape: Solid

Molecular weight: 566

Ref: TM-T15244